7 Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, China Objective Hepatocellular ... 1 had well-differentiated (T2 and T7), moderately differentiated ...

It is under development for the treatment of advanced or metastatic papillary renal cell carcinoma, poorly differentiated thyroid carcinoma ... esophageal squamous cell carcinoma (ESCC), ...

Hepatobiliary cancers, which include biliary tract cancer (BTC) and hepatocellular carcinoma (HCC), are among the most lethal ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

Josep M. Llovet, MD, Senior Investigator, Barcelona-Clínic Liver Cancer (BCLC) Group; Liver Unit, Digestive Disease Institut; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS ...

While undergoing cancer treatment in the 1990s, one mum found a way to communicate what was happening to her toddler "the best way she knew how" - writing. Debra Hanson-Bolus wrote The Poorly Doll ...

A multicenter, phase 2 study of atezolizumab plus bevacizumab (atezo+bev) combination therapy in patients with unresectable hepatocellular carcinoma (HCC) and Child–Pugh class B cirrhosis: CHALLENGE ...

While there currently isn’t a cure for cancer, researchers are exploring several new treatments, including vaccines and gene editing, that could eventually change the face of cancer treatment.

Variations in tumor biology from patient to patient combined with the low overall survival rate of hepatocellular carcinoma (HCC ... HCC still responds very poorly to drugs in general and notably to ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...